Disposition of 694 shares by Virsik Peter of ESSA Pharma at 6.95 subject to Rule 16b-3
| EPIX Stock | USD 1.68 0.02 1.18% |
Slightly above 82 percent of ESSA Pharma's investors are selling. The analysis of the overall investor sentiment regarding ESSA Pharma suggests that a fairly large number of traders are terrified. ESSA Pharma's investing sentiment can be driven by a variety of factors including economic data, ESSA Pharma's earnings reports, geopolitical events, and overall market trends.
ESSA |
Filed transaction by ESSA Pharma Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
ESSA Pharma's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the ESSA Pharma's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
ESSA Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ESSA Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ESSA Pharma Historical Investor Sentiment
Investor biases related to ESSA Pharma's public news can be used to forecast risks associated with an investment in ESSA. The trend in average sentiment can be used to explain how an investor holding ESSA can time the market purely based on public headlines and social activities around ESSA Pharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ESSA Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ESSA Pharma and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ESSA Pharma news discussions. The higher the estimate score, the more favorable the investor's outlook on ESSA Pharma.
ESSA Pharma Fundamental Analysis
We analyze ESSA Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ESSA Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ESSA Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
ESSA Pharma is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
ESSA Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ESSA Pharma stock to make a market-neutral strategy. Peer analysis of ESSA Pharma could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics with similar companies.
Peers
ESSA Pharma Related Equities
| SMMT | Summit Therapeutics | 11.90 | ||||
| SPRO | Spero Therapeutics | 1.27 | ||||
| ATXI | Avenue Therapeutics | 12.00 |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.